| Next 10 |
PTE News and Press, PolarityTE Inc.
-
PolarityTE to Attend H.C. Wainwright Global Investment Conference PR Newswire SALT LAKE CITY , May 23, 2022 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) today announced that Richard Hague , Chief Executive Officer, and Nikolai Sopko , MD, Ph...
-
Gainers: Applied UV (AUVI) +30%. Forge Global Holdings (FRGE) +29%. Jumia Technologies (JMIA) +27%. Sunlight Financial Holdings (SUNL) +26%. Blue Water Vaccines (BWV) +26%. Enthusiast Gaming Holdings (EGLX) +25%. BTCS (BTCS) +24%. Yellow (YELL) +22%. Marpai (MRAI) +21%. Losers: AutoWeb (AUTO)...
-
Gainers: Scholar Rock (SRRK) +26%. Phathom Pharmaceuticals (PHAT) +12%. 4d Pharma (LBPS) +10%. Ocular Therapeutix (OCUL) +9%. Magenta Therapeutics (MGTA) +8%. Losers: PolarityTE (PTE) -34%. Tonix Pharmaceuticals (TNXP) -22%. Albireo Pharma (ALBO) ...
-
PolarityTE (NASDAQ:PTE) has implemented a 1-for-25 reverse stock split of its issued and outstanding common stock, effective May 16, 2022. Each 25 shares of issued and outstanding common stock and equivalents will be converted into one share of common stock. The split is being effectuated to ...
-
PolarityTE to Effectuate 1-for-25 Reverse Stock Split PR Newswire SALT LAKE CITY , May 16, 2022 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) a biotechnology company developing regenerative tissue products and biomaterials, today announced that the C...
-
PolarityTE (NASDAQ:PTE -15.2%) stock fell after the company posted Q1 profit that missed estimates as research and development costs increased during the quarter. The company reported quarterly Non-GAAP EPS of -$0.10, which missed estimates by $0.02. Net revenues declined 84.3% Y/Y to $0.74M,...
-
PolarityTE, Inc. (PTE) Q1 2022 Earnings Conference Call May 16, 2022 8:30 a.m. ET Company Participants Cameron Hoyler - General Counsel Richard Hague - Chief Executive Officer and President Jake Patterson - Chief Financial Officer Conference Call Participants Kristen Kluska - Cantor Fitzgeral...
-
PolarityTE press release (NASDAQ:PTE): Q1 Non-GAAP EPS of -$0.10 misses by $0.02. Revenue of $0.74M (-84.3% Y/Y) beats by $0.01M. "As of March 31, 2022, we had $18.7M in cash and cash equivalents and working capital of approximately $17.2M. We believe cash and cash equivalents on our balance ...
-
PolarityTE Reports First Quarter 2022 Financial Results and Provides Business Update PR Newswire PolarityTE to host conference call and webcast today, May 16, 2022 , at 8:30 a.m. ET SALT LAKE CITY , May 16, 2022 /PRNewswire/ -- PolarityT...
-
PolarityTE (NASDAQ:PTE) is scheduled to announce Q1 earnings results on Monday, May 16th, before market open. The consensus EPS Estimate is -$0.08 (+33.3% Y/Y) and the consensus Revenue Estimate is $0.73M (-84.5% Y/Y). For further details see: PolarityTE Q1 2022 Earnings Preview
Stock Information
MENU
PTE
PTE Quote
PTE Short
PTE News
PTE Articles
Get PTE Alerts
News, Short Squeeze, Breakout and More Instantly...
-
PolarityTE to Attend H.C. Wainwright Global Investment Conference PR Newswire SALT LAKE CITY , May 23, 2022 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) today announced that Richard Hague , Chief Executive Officer, and Nikolai Sopko , MD, Ph...
-
PolarityTE to Effectuate 1-for-25 Reverse Stock Split PR Newswire SALT LAKE CITY , May 16, 2022 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE) a biotechnology company developing regenerative tissue products and biomaterials, today announced that the C...
-
PolarityTE Reports First Quarter 2022 Financial Results and Provides Business Update PR Newswire PolarityTE to host conference call and webcast today, May 16, 2022 , at 8:30 a.m. ET SALT LAKE CITY , May 16, 2022 /PRNewswire/ -- PolarityT...